Lenalidomide and Cyclophosphamide in Treating Patients With Previously Treated Hormone-Refractory Prostate Cancer

Clinical trial NCT01093183 · TERMINATED

Trial details

NCT number: NCT01093183
Sponsor: University of Nebraska
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Adenocarcinoma of the Prostate Hormone-resistant Prostate Cancer Recurrent Prostate Cancer

Start date: 2010-03-04
Primary completion: 2015-05-19
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.